Potentiating interaction of ethoxydol and rosuvastatin in an experimental model of Langendorf-isolated rat heart total ischemia-reperfusion

Abstract

The study of cardioprotective activity showed that in vitro ethoxydol at a dose of 3.8 × 10-4 g/l can significantly improve the morphofunctional state of cardiomyocytes, which is manifested in an increase in the proportion of postischemic cardiac resumption, reduction of ischemic contracture, and recovery of contractility during the reperfusion period